Arylamine N‐acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism
暂无分享,去创建一个
E. Sim | S. Sampson | T. Victor | A. Upton | J. Sandy | A. Mushtaq | P. van Helden | Drake M. Smith | Drake M. Smith | Drake M. Smith | Edith Sim | S. L. Sampson | Anna Upton | Adeel Mushtaq | D. M. Smith | P. V. V. Helden
[1] E. Sim,et al. Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. , 2001, Microbiology.
[2] Annelies Van Rie,et al. Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community , 2001, Journal of Clinical Microbiology.
[3] P. V. van Helden,et al. Mapping of IS6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticity , 2000, Molecular microbiology.
[4] M. Noble,et al. Structure of arylamine N-acetyltransferase reveals a catalytic triad , 2000, Nature Structural Biology.
[5] C. E. Barry,et al. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. , 2000, Microbes and infection.
[6] C. Dye,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.
[7] E. Sim,et al. Cloning and Characterization of Arylamine N -Acetyltransferase Genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: Increased Expression Results in Isoniazid Resistance , 1999, Journal of bacteriology.
[8] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[9] David A. Mead,et al. Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP synthase by isoniazid , 1998 .
[10] H L Rieder,et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 1998, The New England journal of medicine.
[11] J. Sacchettini,et al. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. , 1998, Science.
[12] P. V. van Helden,et al. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. , 1997, Journal of medical microbiology.
[13] D. Rouse,et al. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis , 1997, Antimicrobial agents and chemotherapy.
[14] T. Parish,et al. Regulation of the inducible acetamidase gene of Mycobacterium smegmatis. , 1997, Microbiology.
[15] P. V. van Helden,et al. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. , 1997, American journal of respiratory and critical care medicine.
[16] I. Mills,et al. Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. , 1997, Pharmacogenetics.
[17] J. Unadkat,et al. Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. , 1995, Biochemical pharmacology.
[18] D. Snider,et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. , 1994, American journal of respiratory and critical care medicine.
[19] W. Jacobs,et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.
[20] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[21] S T Cole,et al. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis , 1993, Journal of bacteriology.
[22] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[23] K. Sharp,et al. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.
[24] W. Jacobs,et al. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis , 1990, Molecular microbiology.
[25] John P. Overington,et al. From comparisons of protein sequences and structures to protein modelling and design. , 1990, Trends in biochemical sciences.
[26] T. Blundell,et al. Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming. , 1990, Journal of molecular biology.
[27] W. Weber,et al. N-acetylation pharmacogenetics. , 1985, Pharmacological reviews.
[28] K. Takayama,et al. Effect of Isoniazid on the In Vivo Mycolic Acid Synthesis, Cell Growth, and Viability of Mycobacterium tuberculosis , 1972, Antimicrobial Agents and Chemotherapy.
[29] D. E. Peake. Action in Birmingham , 1965 .
[30] V. McKusick,et al. Genetic Control of Isoniazid Metabolism in Man , 1960, British medical journal.
[31] F. Pansy,et al. THE CHEMOTHERAPY OF EXPERIMENTAL TUBERCULOSIS I , 1950, Journal of bacteriology.
[32] J. Musser,et al. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[33] D van Soolingen,et al. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. , 1996, The Journal of infectious diseases.
[34] P. Routledge,et al. High-performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluids. , 1983, Journal of chromatography.
[35] G. W. Raiziss,et al. Chemotherapy of Experimental Tuberculosis. , 1941 .